Skip to content
Tagged COVID-19 Biotechnology SARS-CoV-2 Life Science cancer CORONAVIRUS pandemic
BioXone

BioXone

rethinking future

June 5, 2025
  • About
  • BiotechTodayNews
    • IndiaWeekly Biotech News of India
    • WorldWeekly Biotech News of The World
  • DNA-TalesArticles
    • BiotechnopediaInteresting articles written by BioXone members and associates.
    • Scientists’ CornerArticles from the pioneers of Biotechnology.
    • Cellular CommunicationInterview of greatest researchers’ in the field.
  • Myth-LysisFact Check
  • Signalling PathwayCareer related updates
    • ExaminationsExamination related articles.
    • Job and InternshipJobs and Internship related articles.
  • Courses
  • Contact

Most Viewed This Week

October 17, 2023October 16, 2023

The Corrosion Prediction from the Corrosion Product Performance

1
October 1, 2023September 30, 2023

Nitrogen Resilience in Waterlogged Soybean plants

2
September 28, 2023September 28, 2023

Cell Senescence in Type II Diabetes: Therapeutic Potential

3
September 26, 2023September 25, 2023

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

4
September 25, 2023September 25, 2023

AI Literacy in Early Childhood Education: Challenges and Opportunities

5
September 22, 2023October 1, 2023

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

6

Search Field

Subscribe Now

  • Home
  • BiotechToday
  • World
  • Page 120

Category: World

Weekly Biotech News of The World

  • BiotechToday
  • India
  • World

HIV (Human Immunodeficiency Virus)- can be cured

bioxone October 3, 2020October 3, 2020

Sambit Majumdar, Amity University Kolkata HIV i.e. Human Immunodeficiency Viruses are two species of Lentivirus that infect humans. It is a virus that attacks the cells in the immune system. This virus destroys a type of white blood cell in the immune system called a T helper cell, also mention as a CD4 cell. This […]

Read More
  • BiotechToday
  • India
  • World

Does an Irregular menstrual cycle come along with a risk of premature deaths?

bioxone October 3, 2020October 3, 2020 2

Arjama Roy, Amity University Kolkata A woman’s menstrual cycle is usually for 28 days. However, this may vary from person to person.  If the length of the menstrual cycle is more than 35 days, or if the duration varies, then we call it irregular periods. It may happen due to hormonal imbalance, changes in contraception, […]

Read More
  • BiotechToday
  • World

COVID update: One out of seven critical COVID cases may result from faulty immune responses

bioxone October 3, 2020October 3, 2020 1

SAGNIK  NAG, AMITY UNIVERSITY KOLKATA Our immune system plays an imperative role in combating the uncertainties of COVID-19. The most concerning fact regarding the ailment is its alarming range of severity – from being asymptotic to completely fatal. Standing today we know all the precautions that are to be followed during this pandemic situation, we […]

Read More
  • BiotechToday
  • World

Dengue, Chikungunya, Zika and COVID-19? A rare mismatch

bioxone October 3, 2020October 2, 2020

Raddur Samaddar, Team bioXone The pandemic is going about its length and breadth, in India, we have 9,43,990 active cases as of 2nd October 2020. The serological activity and also the cross-reactivity of the diseases are a major concern at this moment. A commercial SARS-CoV-2 ELISA test was used for patients diagnosed as Dengue, Zika, […]

Read More
  • BiotechToday
  • India
  • World

Elevation of serum IgA and antiphospholipid-IgA antibodies production in Severe COVID-19

bioxone October 2, 2020October 2, 2020

Anwita Sarkar, Team BioXone Based on what we know so far about the complications of COVID-19, it frequently involves complications that bear similarities to autoimmune disorders. Up to now, there are little reports on possible IgA mediated autoimmune responses. A study was conducted to determine the association of COVID-19 with vigorous total IgA responses. It […]

Read More
  • BiotechToday
  • World

Location of working memory:

bioxone October 2, 2020October 2, 2020

Shrestha Dutta, Amity university Kolkata Working memory is imperative for a successful errand – the capacity to hold information in our minds lies at the core of almost everything we do. In a paper in Cell, the scientists present proof that working memory isn’t perfectly bound to one brain area, but requires the simultaneous activity […]

Read More
  • BiotechToday
  • World

Catalase: Antioxidant Treatment for COVID-19

bioxone October 2, 2020October 1, 2020 1

-Thota Kanishka Rao, Amity University Kolkata Researchers have discovered that a drug, Catalase, might be the solution to the ongoing coronavirus pandemic. Catalase is a naturally occurring enzyme having the potential as a therapeutic drug treat COVID-19 symptom and suppress the replication of the virus inside the body. Catalase is produced naturally and employed by […]

Read More
  • BiotechToday
  • India
  • World

Area 32 establishes parity between your cognitive abilities and emotional expression

bioxone October 2, 2020October 2, 2020

Sristi Raj Rai, Amity University Kolkata Throughout the evolution of the primate’s brain from the rear end to the foremost part – the prefrontal cortex (PFC) makes Homo sapiens the most intelligent species known on this planet. PFC, the rational part of the brain has evolutionarily specialized cognitive abilities such as complex decision making. Due […]

Read More
  • BiotechToday
  • India
  • World

mRNA-1273: A COVID vaccine for the old?

bioxone October 1, 2020October 1, 2020

Prama Ghosh, Amity University Kolkata Severity and death from Coronavirus disease 2019 (Covid-19) are associated with the older population; testing such vaccine candidates is important to prevent infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). A phase 1, open-label trial with an escalated dose of messenger RNA vaccine, mRNA-1273, which encodes the stabilized prefusion […]

Read More
  • BiotechToday
  • World

ODM-207 – First-in-human Phase 1 study of BET inhibitor for solid tumour patients

bioxone October 1, 2020October 1, 2020

RUCHITA KARMAKAR, AMITY UNIVERSITY KOLKATA BET (Bromodomain and extra terminal domain) proteins are described to be epigenetic and anti-cancer drug targets. This was the first-in-human study that judged the pharmacokinetics and prior activity of ODM-20, the inhibitor of BET in patients having solid tumours.  The main objective was to determine the tolerability, dose-limiting toxicities (DLT), […]

Read More

Posts navigation

1 … 116 117 118 119 120 121 122 123 124 … 131

Breaking News

The Corrosion Prediction from the Corrosion Product Performance

Nitrogen Resilience in Waterlogged Soybean plants

Cell Senescence in Type II Diabetes: Therapeutic Potential

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

AI Literacy in Early Childhood Education: Challenges and Opportunities

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

Exogenous Klotho as a Cognition Booster in Aging Primates

Terms and Conditions
Shipping and Delivery Policy
Cancellation and Refund Policy
Contact Us
Privacy Policy